About SafeBVM™

In cardiac arrest, overdose, and brain injury, the difference between surviving and surviving whole often comes down to how one person squeezes a bag. Recent multi-center trials put a number on it: getting manual ventilation right improves neurologically intact survival two- to four-fold. In November 2025, the American Heart Association updated its guidelines around exactly that. The opportunity is to deliver a safe breath every time, everywhere, by every provider.

That is what SafeBVM builds with the Sotair^® Series of products. Adult Sotair^®, our FDA-cleared and Health Canada approved flow-limiting device, fits the standard bag already in use and keeps every breath within the flow-limiting zone, automatically delivering safe pressure specific to each patient. No dials, no screens, 30 seconds to learn. SotairIQ™ makes ventilation skill something providers can see, practice, and prove.

Founded in 2019 and based in Boston, USA, SafeBVM is supported by $8.5 million in non-dilutive funding from the National Institutes of Health, the National Science Foundation, the Department of Defense, and the American Heart Association. Our work is published in BMJ Innovation, Prehospital Emergency Care, and Respiratory Care, and Sotair^® is now in the hands of more than 150 EMS services, hospitals, and military medical teams.